...dont know if I would go that far...but certainly Coronavirus treatment/vaccine candidates seem to be the only ones holding up...
terrific speculative investment since proceeding with its planned Phase 2 clinical trial of Brilacidin in pill form, its defensin mimetic drug candidate with multi-indication potential, as a novel oral medication for the treatment of Ulcerative Colitis (UC) relatively soon after Coronavirus resolution.